AstroFlav Inflammatory Health: The Most Anti-Inflammatory Joint Supplement Yet?

Published on July 21, 2023 by Mike Roberto | 1 Comment

AstroFlav is known (and named) for its astronomically great flavors, and indeed, flavoring is an important part of developing a good supplement.

AstroFlav Logo

However, the AstroFlav team has some serious industry expertise behind it, particularly on the retail side. It was really only a matter of time before they branched out into new supplement categories and capsule-based products. In our recent podcast episode #095 with founder Brian Tweer and VP Brady Adamson, we talked about some of these new formulations like AstroFlav Magnesium, their 2X fat burning support supplement, and the new AstroFlav Multivitamin.

But at the end of the episode, they also teased something else, and it’s finally here:

As Promised on the PricePlow Podcast, AstroFlav Inflammatory Health Has Arrived

AstroFlav Inflammatory Health

AstroFlav Inflammatory Health (formerly AstroFlav Joint Plus) is here! This powerful formula is still loaded with the same incredible number of anti-inflammatory ingredients (and some Type-II collagen) to get your joints and soft tissues under control.

Today, we get to talk about AstroFlav’s joint health supplement — AstroFlav Inflammatory Health.

Joint problems generally involve chronic inflammation, and the first-line therapy is usually a non-steroid anti-inflammatory drug (NSAID) like aspirin, ibuprofen, or acetaminophen. However, NSAIDs come with serious gastrointestinal and hormonal side effects, so not everybody wants to take one on a regular basis.

AstroFlav’s formula emphasizes ingredients that have plenty of mechanisms of action in common with NSAIDs, but with a more forgiving side effect profile.

Besides focusing on anti-inflammatory properties, there are a few ingredients that downregulate the matrix metalloproteinase enzymes, which can damage the collagenous and cartilaginous tissue. The MMPs are typically overexpressed in, for example, osteoarthritis (OA).

Plus, there’s a little support in here for the synthesis of new, healthy collagen.

Let’s get into it, but first, let’s check PricePlow’s coupon-powered prices and get you signed up for more AstroFlav news:

AstroFlav Inflammatory Health – Deals and Price Drop Alerts

Get Price Alerts

No spam, no scams.

Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.

Posts are sponsored in part by the retailers and/or brands listed on this page.

This area is reserved for Team PricePlow's upcoming videos.

Subscribe to our channel and sign up for notifications so you catch it when it goes live!

Subscribe to PricePlow on YouTube!

AstroFlav Inflammatory Health Ingredients

In a single 2 capsule serving of Inflammatory Health from AstroFlav, you get the following:

  • MicroActive Curcumin (micronized sustained-release curcuminoid matrix: curcumin, demethoxycurcumin, bisdemethosycurcumin) – 500 mg

    AstroFlav Inflammatory Health Ingredients

    Curcumin is the famous bright yellow-orange pigment that occurs naturally in turmeric root.[1] Despite technically referring to a specific molecule, the term “curcumin” is also used to refer to the entire family of related curcuminoid compounds. The curcuminoids have profound anti-inflammatory effects, which is the main reason that turmeric has been used for thousands of years in several systems of traditional medicine.[2]

    Although curcuminoid research emphasizes curcumin specifically, all curcuminoids have similar anti-inflammatory activity.[3] Besides reducing inflammation,[4-9] the they also work to bring the body’s level of oxidative stress down.[10-16] This two-fold effect makes sense, since inflammation and oxidative stress are closely related.[17]

    Improving inflammation and oxidative stress has tons of knock-on effects. Thanks to this, the curcuminoids have been identified as being useful for liver, cardiovascular, and neurological health.[18]

    Curcuminoids’ anti-inflammatory mechanism – COX-2

    As it turns out, curcuminoids actually inhibit cyclooxygenase-2 (COX-2),[19-22] an enzyme responsible for synthesizing inflammatory prostaglandins.[23] This is the same enzyme inhibited by ubiquitous over-the-counter anti-inflammatory drugs like aspirin and ibuprofen, so it’s no wonder that curcumin has been shown to significantly improve chronic pain.[24-37]

    Osteoarthritis improvement

    When it comes to joint health, there’s a ton of research showing curcumin can potentially help improve osteoarthritis symptoms.[24-37]

    One randomized controlled trial using curcumin for knee pain found that 500 mg of turmeric extract per day for 4 months reduced the incidence of joint crepitation by 60%, joint stiffness by 64%, and joint effusion by 75.8%.[38] I.e., of the subjects who had knee crepitation at the beginning of the study, 60% of them saw this symptom resolve by the end of the treatment period.

  • Quercefit Quercetin Phytosome (Sophora japonica L. extract(flower), phospholipids) – 250 mg

    Quercetin is a flavonoid polyphenol found in many familiar foods, including coffee, onions, orange juice, and red wine.[39] It has significant antioxidant, anti-inflammatory, anti-platelet, antiviral, anti-carcinogenic, and anti-allergenic properties effects.[39,40] It’s also been shown to decrease lipid peroxidation and strengthen blood vessels.[39,40]

    Again, it’s the anti-inflammatory side of quercetin that makes it a great candidate for supporting joint health. Quercetin is so effective in downregulating inflammatory messengers like histamine, cytokines, and interleukin-4[40] that it can actually help minimize joint and and improve functional movement abilities in rheumatoid arthritis (RA) patients.[41]

    A rat study found that quercetin inhibits adenosine deaminase, an inflammatory enzyme whose activity makes RA symptoms worse.[42] The same study found that quercetin can downregulate RA-related cytokines like interleukin-1β, interleukin-6, tumor necrosis factor-α, rheumatoid factor, and C-reactive protein.[42]

    If you’re a caffeine addict – and let’s face it, who isn’t at this point – you’ll probably be glad to learn that quercetin works synergistically with caffeine to improve fatigue and mood.[43] And on the note of caffeine, the biggest question is how you get it from AstroFlav: In the One Scoop Only pre-workout or MetaBurn AM fat burner?!

  • Bromelain (std. to 2,400GDU/g) – 175 mg

    AstroFlav Inflammatory Health

    Bromelain is a proteolytic digestive enzyme. Its normal physiological role is to help break down protein in your digestive tract, thus increasing your body’s ability to absorb and use that protein.

    However, proteolytic enzymes are being recognized for their ability to clear out unwanted proteinaceous compounds from the human body.[44,45] In a nutshell, certain conditions associated with aging, like atherosclerosis and fibrosis, are driven by the accumulation of protein-containing scar tissue. Enzymes like bromelain can help dissolve this scar tissue by breaking down the proteins it contains.[46,47]

    At the same time, bromelain seems to protect our healthy proteinaceous tissue, as shown in an study where it prevented collagen in animals’ joints from being damaged by systemic inflammation.[48]

    Bromelain also seems to help reduce inflammation directly,[48] and improve circulation[49] – two crucial factors in managing chronic joint pain.

    A 2002 randomized controlled trial found that 200 mg of bromelain per day significantly reduced knee pain in otherwise healthy adults with osteoarthritis or rheumatoid arthritis.[50]

  • ApresFlex (Boswellia serrata) (gum resin)[std. to 20% 3-0-acetyl-11-keto-B-boswellic acid(AKBA)] – 100 mg

    Boswellic acid (AKBA), the primary bioactive constituent of Boswellia serrata, has been shown to have significant anti-inflammatory effects.[51]

    It’s been shown to downregulate an enzyme called 5-lipoxygenase (LOX-5),[52,53] which is responsible for driving lipid peroxidation, the generation of lipid peroxides from the metabolism of polyunsaturated fatty acids (PUFAs).Lipid peroxidation is a highly pro-inflammatory process,[54-56] so inhibiting LOX-5 ultimately has an anti-inflammatory effect.

    Since we discussed the fact that curcumin is a COX inhibitor, it’s interesting to note that dual COX and LOX-5 inhibitor compounds, which are extremely effective in decreasing inflammation, have been proposed as the next generation of non-steroidal anti-inflammatory drugs (NSAIDs) – replacements for mainstays like aspirin and ibuprofen.[57] In light of this, it makes a lot of sense for AstroFlav to stack curcumin and AKBA.

    Other studies have found that AKBA can downregulate inflammatory cytokines like tumor necrosis factor alpha (TNF-α).[58-60]

    One randomized, double-blind, placebo-controlled study found that a standardized Boswellia serrata extract is capable of dose-dependently improving OA patients’ scores on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), a questionnaire used to quantify the severity of knee pain.[61]

    Boswellia Benefits: Pain and Stiffness

    Subjects taking 100 mg or 250 mg of a standardized Boswellia serrata extract per day saw significant improvements in their scores on the WOMAC index, an inventory used to quantify knee pain in osteoarthritis patients.[61]

    Boswellia MMP-3

    Boswellia extract decreased the expression of an enzyme that degrades collagen.[61]

    This study also found that the Boswellia extract downregulated matrix metalloproteinase 3 (MMP-3), an enzyme that breaks down collagen and is overexpressed in OA patients.[61] Since collagen is a major constituent of joint tissue, it’s not surprising that a compound with beneficial effects in OA would have this collagen-protective effect.

    At least two other RCTs have reached similar conclusions.[62,63]

  • Ginger Root Extract (Zingiber officinale) (5% gingerols) – 100 mg

    Ginger is closely related in its chemical composition and biological effect to turmeric. Like turmeric, it has been identified as a potent anti-inflammatory spice.[64,65]

    The gingerols and shogaols in ginger have been shown to downregulate pro-inflammatory cytokines like interleukins 1 and 8 (IL-1, IL-8) and tumor necrosis factor alpha (TNF-α). They do this by familiar mechanisms of action – LOX-5 and COX inhibition.[66,67] One specific shogaol, 6-shogaol, has also been shown to downregulate inducible nitric oxide synthase (iNOS), an enzyme that contributes to inflammation by generating excessive nitric oxide (NO) in places we don’t want it[68] – in simple terms, we want NO from endothelial nitric oxide synthase (eNOS), not iNOS.

    Ginger Knee Pain

    In a randomized controlled trial, OA patients who took ginger extract reported a significantly greater reduction in knee pain than the placebo group.[69]

    In one study, osteoarthritis (OA) patients were randomized to receive either 255 mg of ginger extract, or a placebo for 6 weeks. By the end of the study period, the ginger group reported significantly greater improvements in knee pain and WOMAC score.[69] When it came to the WOMAC, the ginger group’s score was reduced by an average of 12.9 points, compared to the placebo group’s 9.0.[69] The ginger group also reported significantly less knee pain on standing, and on walking 50 feet.[69]

    But we’re not done with ginger just yet!

  • Black Ginger Extract (Kaempferia parviflora)(rhizome)(std. to NLT 5% 5,7-dimethoxyflavone) – 100 mg

    Thai black ginger (KP) is a traditional Thai adaptogen[70] that’s rich in polymethoxyflavones, a category of flavonoid antioxidants with impressively broad benefits.

    Black Ginger (Kaempferia parviflora)

    Black Ginger (Kaempferia parviflora) looks like ginger, but is darker inside! And this brings some serious anti-inflammatory potency. Image courtesy Wikimedia.

    We often see KP used in pre-workout and NO-boosting formulas, because it’s awesome at improving multiple dimensions of athletic performance. Randomized controlled trials have found that athletes taking KP have higher grip strength and leg strength, faster sprint times, and even better hip and upper body flexibility.[70] This is due mostly to KP’s profound impact on cardiorespiratory performance.

    KP Has also been shown to activate peroxisome proliferator-activated receptor (PPAR) gamma[71] and AMP-activated protein kinase (AMPK),[72] which increases your rate of fat burning and decreases the amount of fat your body stores.[73,74] KP also seems to drive mitochondrial biogenesis and respiration.[75] Admittedly, none of this is directly related to joint health, but we think it’s worth mentioning that KP seems to be something of a metabolic panacea.

    The things we like about black ginger for joints are its vasodilatory effects, which can improve circulation,[76] and more importantly, its anti-inflammatory activity.[77]

    Much like ginger, KP has been shown to downregulate iNOS,[78] while upregulating eNOS.[79] This is exactly what we want if our goal is to decrease inflammation by manipulating the NO system.

    Besides downregulating iNOS, KP’s other anti-inflammatory mechanism is COX inhibition.[77]

    A 2019 study reports that KP extract improved pain threshold and decreased the severity of osteoarthritic lesions in an animal model of OA. Further investigation using human chondrocytes (the cells responsible for producing joint collagen) found that the extract worked to protect cartilaginous tissue by downregulating matrix metalloproteinases 1 and 3 (MMP-1, MMP-3).[80]

    Black Ginger Extract Kaempferia Parviflora and Osteoarthritis

    Black Ginger (Kaempferia parviflora) extract improved osteoarthritis and histopathological markers of arthritis in a rat model.[81]

    In a 2021 study, researchers looked at the effects that two different doses of KP extract had on rat OA. They found that while both KP groups (K150, 150 mg/kg/day and and KP 300, 300 mg/kg/day) showed significant improvements in OA symptoms and histopathology, the low-dose group, KP150, actually did better than the higher-dose group. Still, even the higher-dose group, marked KP300, in our images from this study, saw improvements comparable to those experienced by rats who got the NSAID indomethacin.[81]

    As you can see, this is an incredibly promising ingredient for Inflammatory Health – Brady and his team did a fantastic job including it.

  • Type II Collagen Peptides (providing 42 mgs total type II collagen) – 60 mg

    AstroFlav Collagen

    Collagen type II is the collagen your body uses to make cartilage,[82] making this type of collagen especially important for joint health.

    Human studies have shown that collagen type II supplementation can significantly improve joint pain in both osteoarthritis and rheumatoid arthritis,[83,84] allowing them to exercise for longer before experiencing pain, and enjoy a greater range of motion (ROM) in the affected joints.[83]

    Collagen type II’s ability to increase ROM has actually been quantified – the effect size is between 3 and 5 degrees of additional flexion.[85]

    Need even more collagen? Then check out our article on AstroFlav Collagen, which adds an incredible anti-aging ingredient to the mix.

  • Tetrahydrocurcumin – 25 mg

    Tetrahydrocurcumin is the primary metabolite of curcumin, with basically the same benefits as curcumin itself, yet targeting some different pathways as well.[86] Compared to curcumin, this metabolite is significantly more bioavailable, and has greater antioxidant activity.[86] Like curcumin, tetrahydrocurcumin has been shown to reduce inflammation by downregulating certain interleukins.[87]

    Curcumin vs. Tetrahydrocurcumin

    Targets of Curcumin vs. Tetrahydrocurcumin: Curcumin is more effective in modulating some, but tetrahydrocurcumin is more effective in others.[86] Not all molecules are targeted by both, and this is why AstroFlav is smart by including both ingredients!

    At least one study has put curcumin and tetrahydrocurcumin head-to-head, and found that both are about equally as effective at preventing OA-related symptoms in estrogen-deficient rats.[88] In fact, curcumin and tetrahydrocurcumin did better at managing the OA symptoms than actually correcting the estrogen deficiency!

    If you want to learn more, check out our article Tetrahydrocurcumin: A More Potent Alternative to Curcumin?

  • AstraGin [Astragalus membranaceus (root), Panax notoginseng (root)] – 50 mg

    AstraGin from NuLiv Science is a patented bioavailability enhancer.[38,89-92] It works by helping your intestinal cells synthesize adenosine triphosphate (ATP), the form of usable energy they need to fuel their absorption of nutrients from the food and supplements you ingest.

    By improving intestinal cell function, AstraGin helps you absorb and use more of whatever other supplements you take it with.

    When taken regularly, it can even help improve the health of your intestinal tissue.[93]

  • Bioperine (std. to 95% piperine) – 10 mg

    AstroFlav Joint Supplement

    Piperine, the main bioactive constituent of BioPerine black pepper extract, helps downregulate certain stomach enzymes. In doing so, piperine helps prevent nutrients from being broken down in your stomach, before they can reach your intestines for absorption into your bloodstream.[94]

    Piperine also has some metabolic benefits – it can increase insulin sensitivity by upregulating glucose transporter 4 (GLUT4),[95] and helps prevent fat buildup in the liver.[96] It’s also a potent antioxidant.[97]

    Piperine is very good at improving curcumin absorption

    So you can see that BioPerine does a lot of the same stuff as AstraGin. Why, then, is AstroFlav using both?

    The answer is that piperine is incredibly effective in boosting the bioavailability of curcumin. On its own, the bioavailability of curcumin isn’t very good,[98] but BioPerine has been shown to increase curcumins absorption by a whopping 2,000%![99]

Dosage, Directions, and Stacking

Per AstroFlav’s label, take one serving (2 capsules) daily on an empty stomach.

AstroFlav Inflammatory Health

AstroFlav Inflammatory Health (formerly AstroFlav Joint Plus) is here! This powerful formula is still loaded with the same incredible number of anti-inflammatory ingredients (and some Type-II collagen) to get your joints and soft tissues under control.

As for stacking, if you’re looking for more collagen, then you came to the right place, because AstroFlav Collagen is a premium form with an added anti-aging twist that we especially like!

Also, we’d add in AstroFlav Magnesium, another incredible capsule formulation. Nearly everyone should be supplementing magnesium by default these days!

AstroFlav Inflammatory Health: The Joint Supplement of the Year?

Every ingredient in this formula, except for AstraGin and BioPerine, has been shown to possess systemic anti-inflammatory effects, which is really the name of the game when it comes to supporting joint health. However, AstroFlav has also made sure to use some ingredients that downregulate the matrix metalloproteinase (MMP) enzymes, while supporting healthy collagen synthesis.

Joint health is a very diverse category of supplements – the industry hasn’t really settled on a standard approach or set of ingredients, so you may commonly see a lot of obscure stuff show up in these formulas, and overall quality can vary wildly. This isn’t an exception, but Brady and his team really came through with some science-backed anti-inflammatory support here.

If you’ve tried a few joint supplements and want something powerful and different, this is absolutely the new one of the year we’d suggest running.

AstroFlav Inflammatory Health – Deals and Price Drop Alerts

Get Price Alerts

No spam, no scams.

Disclosure: PricePlow relies on pricing from stores with which we have a business relationship. We work hard to keep pricing current, but you may find a better offer.

Posts are sponsored in part by the retailers and/or brands listed on this page.

About the Author: Mike Roberto

Mike Roberto

Mike Roberto is a research scientist and water sports athlete who founded PricePlow. He is an n=1 diet experimenter with extensive experience in supplementation and dietary modification, whose personal expertise stems from several experiments done on himself while sharing lab tests.

Mike's goal is to bridge the gap between nutritional research scientists and non-academics who seek to better their health in a system that has catastrophically failed the public. Mike is currently experimenting with a low Vitamin A diet.

1 Comment | Posted in | Tagged , , , , , , , , , , , , , , , , , , , , , , , , .

References

  1. DiSilvestro, Robert A, et al. “Diverse Effects of a Low Dose Supplement of Lipidated Curcumin in Healthy Middle Aged People.” Nutrition Journal, vol. 11, no. 1, 26 Sept. 2012, 10.1186/1475-2891-11-79; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518252/
  2. Jayaprakasha, G.K., et al. “Chemistry and Biological Activities of C. Longa.” Trends in Food Science & Technology, vol. 16, no. 12, Dec. 2005, pp. 533–548, 10.1016/j.tifs.2005.08.006; https://www.sciencedirect.com/science/article/abs/pii/S0924224405002049
  3. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review. J Tradit Complement Med. 2016 Jun 15;7(2):205-233. doi: 10.1016/j.jtcme.2016.05.005; https://pubmed.ncbi.nlm.nih.gov/28417091/
  4. Belcaro, Gianni, et al. “Efficacy and Safety of Meriva®, a Curcumin-Phosphatidylcholine Complex, during Extended Administration in Osteoarthritis Patients.” Alternative Medicine Review: A Journal of Clinical Therapeutic, vol. 15, no. 4, 1 Dec. 2010, pp. 337–344; https://pubmed.ncbi.nlm.nih.gov/21194249/
  5. Chainani-Wu, Nita, et al. “High-Dose Curcuminoids Are Efficacious in the Reduction in Symptoms and Signs of Oral Lichen Planus.” Journal of the American Academy of Dermatology, vol. 66, no. 5, May 2012, pp. 752–760, 10.1016/j.jaad.2011.04.022; https://pubmed.ncbi.nlm.nih.gov/21907450/
  6. Khajehdehi, Parviz, et al. “Oral Supplementation of Turmeric Attenuates Proteinuria, Transforming Growth Factor-β and Interleukin-8 Levels in Patients with Overt Type 2 Diabetic Nephropathy: A Randomized, Double-Blind and Placebo-Controlled Study.” Scandinavian Journal of Urology and Nephrology, vol. 45, no. 5, 31 May 2011, pp. 365–370, 10.3109/00365599.2011.585622; https://pubmed.ncbi.nlm.nih.gov/21627399/
  7. Khajehdehi, Parviz, et al. “Oral Supplementation of Turmeric Decreases Proteinuria, Hematuria, and Systolic Blood Pressure in Patients Suffering from Relapsing or Refractory Lupus Nephritis: A Randomized and Placebo-Controlled Study.” Journal of Renal Nutrition, vol. 22, no. 1, Jan. 2012, pp. 50–57, 10.1053/j.jrn.2011.03.002; https://pubmed.ncbi.nlm.nih.gov/21742514/
  8. Hanai, Hiroyuki, et al. “Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.” Clinical Gastroenterology and Hepatology, vol. 4, no. 12, Dec. 2006, pp. 1502–1506, 10.1016/j.cgh.2006.08.008; https://pubmed.ncbi.nlm.nih.gov/17101300/
  9. Amalraj, Augustine, et al. “A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.” Journal of Medicinal Food, vol. 20, no. 10, 2017, pp. 1022–1030, 10.1089/jmf.2017.3930; https://pubmed.ncbi.nlm.nih.gov/28850308/
  10. Prasad, S., & Aggarwal, B. (2011). Turmeric, the Golden Spice. Oxidative Stress and Disease Herbal Medicine, 263-288. doi:10.1201/b10787-14; https://www.ncbi.nlm.nih.gov/books/NBK92752/
  11. DiSilvestro, Robert A, et al. “Diverse Effects of a Low Dose Supplement of Lipidated Curcumin in Healthy Middle Aged People.” Nutrition Journal, vol. 11, no. 1, 26 Sept. 2012, 10.1186/1475-2891-11-79; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518252/
  12. Kalpravidh, Ruchaneekorn W., et al. “Improvement in Oxidative Stress and Antioxidant Parameters in Beta-Thalassemia/Hb E Patients Treated with Curcuminoids.” Clinical Biochemistry, vol. 43, no. 4-5, 1 Mar. 2010, pp. 424–429, 10.1016/j.clinbiochem.2009.10.057; https://pubmed.ncbi.nlm.nih.gov/19900435/
  13. Baum, Larry, et al. “Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients with Alzheimer Disease.” Journal of Clinical Psychopharmacology, vol. 28, no. 1, Feb. 2008, pp. 110–113, 10.1097/jcp.0b013e318160862c; https://pubmed.ncbi.nlm.nih.gov/18204357/
  14. Biswas, Jaydip, et al. “Curcumin Protects DNA Damage in a Chronically Arsenic-Exposed Population of West Bengal.” Human & Experimental Toxicology, vol. 29, no. 6, 1 June 2010, pp. 513–524, 10.1177/0960327109359020; https://pubmed.ncbi.nlm.nih.gov/20056736/
  15. Srivastava, Shobhit, et al. “Curcuma Longa Extract Reduces Inflammatory and Oxidative Stress Biomarkers in Osteoarthritis of Knee: A Four-Month, Double-Blind, Randomized, Placebo-Controlled Trial.” Inflammopharmacology, vol. 24, no. 6, 19 Oct. 2016, pp. 377–388, 10.1007/s10787-016-0289-9; https://pubmed.ncbi.nlm.nih.gov/27761693/
  16. T Krishnareddy, Naveen, et al. “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, Randomized, Placebo-Controlled Study.” BioMed Research International, vol. 2018, 2018, p. 9159281, 10.1155/2018/9159281; https://pubmed.ncbi.nlm.nih.gov/30345312/
  17. Lugrin, Jérôme et al. “The role of oxidative stress during inflammatory processes.” Biological chemistry vol. 395,2 (2014): 203-30. doi:10.1515/hsz-2013-0241 https://www.degruyter.com/document/doi/10.1515/hsz-2013-0241/html
  18. Xu XY, Meng X, Li S, Gan RY, Li Y, Li HB. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients. 2018 Oct 19;10(10):1553. doi: 10.3390/nu10101553; https://pubmed.ncbi.nlm.nih.gov/30347782/
  19. Soleimani, V., Sahebkar, A., & Hosseinzadeh, H. (2018). Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytotherapy Research, 32(6), 985-995; doi:10.1002/ptr.6054; https://onlinelibrary.wiley.com/doi/10.1002/ptr.6054
  20. Camacho-Barquero, Laura, et al. “Curcumin, a Curcuma Longa Constituent, Acts on MAPK P38 Pathway Modulating COX-2 and INOS Expression in Chronic Experimental Colitis.” International Immunopharmacology, vol. 7, no. 3, Mar. 2007, pp. 333–342, 10.1016/j.intimp.2006.11.006; https://pubmed.ncbi.nlm.nih.gov/17276891/
  21. Aggarwal, Sita, et al. “Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IkappaBalpha Kinase and Akt Activation.” Molecular Pharmacology, vol. 69, no. 1, 2006, pp. 195–206, 10.1124/mol.105.017400; https://pubmed.ncbi.nlm.nih.gov/16219905/
  22. Li, Cheng et al. “Curcuminoids: Implication for inflammation and oxidative stress in cardiovascular diseases.” Phytotherapy research: PTR vol. 33,5 (2019): 1302-1317. doi:10.1002/ptr.6324; https://onlinelibrary.wiley.com/doi/10.1002/ptr.6324
  23. Koeberle A, Northoff H, Werz O. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol Cancer Ther. 2009 Aug;8(8):2348-55. doi: 10.1158/1535-7163.MCT-09-0290; https://pubmed.ncbi.nlm.nih.gov/19671757/
  24. Srivastava, Shobhit, et al. “Curcuma Longa Extract Reduces Inflammatory and Oxidative Stress Biomarkers in Osteoarthritis of Knee: A Four-Month, Double-Blind, Randomized, Placebo-Controlled Trial.” Inflammopharmacology, vol. 24, no. 6, 19 Oct. 2016, pp. 377–388, 10.1007/s10787-016-0289-9; https://pubmed.ncbi.nlm.nih.gov/27761693/
  25. Belcaro, Gianni, et al. “Efficacy and Safety of Meriva®, a Curcumin-Phosphatidylcholine Complex, during Extended Administration in Osteoarthritis Patients.” Alternative Medicine Review: A Journal of Clinical Therapeutic, vol. 15, no. 4, 1 Dec. 2010, pp. 337–344; https://pubmed.ncbi.nlm.nih.gov/21194249/
  26. Panahi, Yunes, et al. “Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Trial.” Phytotherapy Research, vol. 28, no. 11, 22 May 2014, pp. 1625–1631, 10.1002/ptr.5174; https://pubmed.ncbi.nlm.nih.gov/24853120/
  27. Belcaro, G., et al. “Product-Evaluation Registry of Meriva®, a Curcumin-Phosphatidylcholine Complex, for the Complementary Management of Osteoarthritis.” Panminerva Medica, vol. 52, no. 2 Suppl 1, 1 June 2010, pp. 55–62; https://pubmed.ncbi.nlm.nih.gov/20657536/
  28. Togni, et al. “Comparative Evaluation of the Pain-Relieving Properties of a Lecithinized Formulation of Curcumin (Meriva®), Nimesulide, and Acetaminophen.” Journal of Pain Research, Mar. 2013, p. 201, 10.2147/jpr.s42184; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596124/
  29. Agarwal, Krishna Adit, et al. “Efficacy of Turmeric (Curcumin) in Pain and Postoperative Fatigue after Laparoscopic Cholecystectomy: A Double-Blind, Randomized Placebo-Controlled Study.” Surgical Endoscopy, vol. 25, no. 12, 14 June 2011, pp. 3805–3810, 10.1007/s00464-011-1793-z; https://pubmed.ncbi.nlm.nih.gov/21671126/
  30. Madhu, K., et al. “Safety and Efficacy of Curcuma Longa Extract in the Treatment of Painful Knee Osteoarthritis: A Randomized Placebo-Controlled Trial.” Inflammopharmacology, vol. 21, no. 2, 16 Dec. 2012, pp. 129–136, 10.1007/s10787-012-0163-3; https://pubmed.ncbi.nlm.nih.gov/23242572/
  31. Nakagawa, Yasuaki, et al. “Short-Term Effects of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Prospective Study.” Journal of Orthopaedic Science, vol. 19, no. 6, Nov. 2014, pp. 933–939, 10.1007/s00776-014-0633-0; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244558/
  32. Haroyan, Armine, et al. “Efficacy and Safety of Curcumin and Its Combination with Boswellic Acid in Osteoarthritis: A Comparative, Randomized, Double-Blind, Placebo-Controlled Study.” BMC Complementary and Alternative Medicine, vol. 18, no. 1, 9 Jan. 2018, 10.1186/s12906-017-2062-z; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761198/
  33. Kuptniratsaikul, Vilai, et al. “Efficacy and Safety of Curcuma Domestica Extracts Compared with Ibuprofen in Patients with Knee Osteoarthritis: A Multicenter Study.” Clinical Interventions in Aging, vol. 9, Mar. 2014, p. 451, 10.2147/cia.s58535; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964021/
  34. Panda, Sanjib kumar, et al. “A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OA.” BioMed Research International, vol. 2018, 25 Oct. 2018, pp. 1–8, 10.1155/2018/5291945; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222223/
  35. Chandran, Binu, and Ajay Goel. “A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis.” Phytotherapy Research, vol. 26, no. 11, 9 Mar. 2012, pp. 1719–1725, 10.1002/ptr.4639; https://pubmed.ncbi.nlm.nih.gov/22407780/
  36. Amalraj, Augustine, et al. “A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.” Journal of Medicinal Food, vol. 20, no. 10, 2017, pp. 1022–1030, 10.1089/jmf.2017.3930; https://pubmed.ncbi.nlm.nih.gov/28850308/
  37. Shep, Dhaneshwar, et al. “Safety and Efficacy of Curcumin versus Diclofenac in Knee Osteoarthritis: A Randomized Open-Label Parallel-Arm Study.” Trials, vol. 20, no. 1, 11 Apr. 2019, 10.1186/s13063-019-3327-2; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460672/
  38. Lin, Hang-Ching, et al. “Method for Regulating Nutrient Absorption with Ginsenosides”; United States Patent and Trademark Office; Patent US20090181904A1; July 16, 2009; https://patents.google.com/patent/US20090181904A1/
  39. Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients. 2016;8(3):167; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808895/
  40. Mlcek J, et al; “Quercetin and Its Anti-Allergic Immune Response”; Molecules. 2016;21(5):623; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273625/
  41. Javadi, Fatemeh et al.; “The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial.”; Journal of the American College of Nutrition vol. 36,1 (2017): 9-15. doi:10.1080/07315724.2016.1140093; https://pubmed.ncbi.nlm.nih.gov/27710596/
  42. El-Said, Karim Samy et al. “Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats.” Molecular medicine (Cambridge, Mass.) vol. 28,1 24. 22 Feb. 2022, doi:10.1186/s10020-022-00432-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862293/
  43. Olson CA, et al; “Effects of 2 adenosine antagonists, quercetin and caffeine, on vigilance and mood”; J Clin Psychopharmacol. (2010); https://pubmed.ncbi.nlm.nih.gov/20814335/
  44. Henrotin, Yves E et al. “Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: Lessons from a Narrative Review of the Literature.” Rheumatology and therapy vol. 9,5 (2022): 1305-1327. doi:10.1007/s40744-022-00472-7; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510077/
  45. Bolten, Wolfgang W et al. “The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial.” Arthritis vol. 2015 (2015): 251521. doi:10.1155/2015/251521 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329848/
  46. Sayed, Amany A et al. “Bromelain mitigates liver fibrosis via targeting hepatic stellate cells in vitro and in vivo.” Tissue & cell vol. 82 (2023): 102118. doi:10.1016/j.tice.2023.102118; https://linkinghub.elsevier.com/retrieve/pii/S0040-8166(23)00106-4
  47. Rathnavelu, Vidhya et al. “Potential role of bromelain in clinical and therapeutic applications.” Biomedical reports vol. 5,3 (2016): 283-288. doi:10.3892/br.2016.720 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998156/
  48. Pothacharoen, Peraphan et al. “Bromelain Extract Exerts Antiarthritic Effects via Chondroprotection and the Suppression of TNF-α-Induced NF-κB and MAPK Signaling.” Plants (Basel, Switzerland) vol. 10,11 2273. 23 Oct. 2021, doi:10.3390/plants10112273 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625807/
  49. Bakhshi, Girish D., et al. “Systemic Enzyme Therapy in Chronic Venous Disease: A Review.” International Journal of Research in Medical Sciences, vol. 9, no. 9, 25 Aug. 2021, pp. 2869–2876; https://www.msjonline.org/index.php/ijrms/article/view/9909
  50. Walker, A F et al. “Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 9,8 (2002): 681-6. doi:10.1078/094471102321621269; https://www.sciencedirect.com/science/article/abs/pii/S0944711304701749
  51. Singh, G B, and C K Atal. “Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent.” Agents and actions vol. 18,3-4 (1986): 407-12. doi:10.1007/BF01965005; https://link.springer.com/article/10.1007/BF01965005
  52. ‌Safayhi, H et al. “Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.” The Journal of pharmacology and experimental therapeutics vol. 261,3 (1992): 1143-6. https://jpet.aspetjournals.org/content/261/3/1143.long
  53. Sailer, E R et al. “Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.” British journal of pharmacology vol. 117,4 (1996): 615-8. doi:10.1111/j.1476-5381.1996.tb15235.x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909340/
  54. Zhong, Shanshan et al. “An update on lipid oxidation and inflammation in cardiovascular diseases.” Free radical biology & medicine vol. 144 (2019): 266-278. doi:10.1016/j.freeradbiomed.2019.03.036; https://linkinghub.elsevier.com/retrieve/pii/S0891-5849(19)30271-0
  55. Dias, Irundika H K et al. “Inflammation, Lipid (Per)oxidation, and Redox Regulation.” Antioxidants & redox signaling vol. 33,3 (2020): 166-190. doi:10.1089/ars.2020.8022; https://www.liebertpub.com/doi/10.1089/ars.2020.8022
  56. Leong, Xin-Fang. “Lipid Oxidation Products on Inflammation-Mediated Hypertension and Atherosclerosis: A Mini Review.” Frontiers in nutrition vol. 8 717740. 30 Sep. 2021, doi:10.3389/fnut.2021.717740; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514637/
  57. Martel-Pelletier, J. “Therapeutic Role of Dual Inhibitors of 5-LOX and COX, Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs.” Annals of the Rheumatic Diseases, vol. 62, no. 6, 1 June 2003, pp. 501–509, doi:10.1136/ard.62.6.501; https://ard.bmj.com/content/62/6/501
  58. Roy, Sashwati et al. “Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells.” DNA and cell biology vol. 24,4 (2005): 244-55. doi:10.1089/dna.2005.24.244; https://www.liebertpub.com/doi/10.1089/dna.2005.24.244
  59. Syrovets, Tatiana et al. “Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases.” Journal of immunology (Baltimore, Md. : 1950) vol. 174,1 (2005): 498-506. doi:10.4049/jimmunol.174.1.498; https://journals.aai.org/jimmunol/article/174/1/498/72237/Acetyl-Boswellic-Acids-Inhibit-Lipopolysaccharide
  60. Roy, Sashwati et al. “Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia.” Antioxidants & redox signaling vol. 8,3-4 (2006): 653-60. doi:10.1089/ars.2006.8.653; https://www.liebertpub.com/doi/10.1089/ars.2006.8.653
  61. Sengupta, Krishanu et al. “A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.” Arthritis research & therapy vol. 10,4 (2008): R85. doi:10.1186/ar2461; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575633/
  62. Kimmatkar, N et al. “Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 10,1 (2003): 3-7. doi:10.1078/094471103321648593; https://www.sciencedirect.com/science/article/abs/pii/S0944711304701890
  63. Sengupta, Krishanu et al. “Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.” International journal of medical sciences vol. 7,6 366-77. 1 Nov. 2010, doi:10.7150/ijms.7.366; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974165/
  64. Mashhadi, Nafiseh Shokri et al. “Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence.” International journal of preventive medicine vol. 4,Suppl 1 (2013): S36-42; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665023/
  65. Bliddal, H, et al. “A Randomized, Placebo-Controlled, Cross-over Study of Ginger Extracts and Ibuprofen in Osteoarthritis.” Osteoarthritis and Cartilage, vol. 8, no. 1, Jan. 2000, pp. 9–12, 10.1053/joca.1999.0264; https://pubmed.ncbi.nlm.nih.gov/10607493/
  66. Tjendraputra, E et al. “Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells.” Bioorganic chemistry vol. 29,3 (2001): 156-63. doi:10.1006/bioo.2001.1208; https://www.sciencedirect.com/science/article/abs/pii/S0045206801912088
  67. Verma, S K et al. “Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits.” Indian journal of experimental biology vol. 42,7 (2004): 736-8. https://nopr.niscpr.res.in/bitstream/123456789/23544/1/IJEB%2042(7)%20736-738.pdf
  68. Pan, Min-Hsiung et al. “6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression.” Molecular nutrition & food research vol. 52,5 (2008): 527-37. doi:10.1002/mnfr.200700157 https://onlinelibrary.wiley.com/doi/10.1002/mnfr.200700157
  69. Altman, R D, and K C Marcussen. “Effects of a ginger extract on knee pain in patients with osteoarthritis.” Arthritis and rheumatism vol. 44,11 (2001): 2531-8. doi:10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j https://onlinelibrary.wiley.com/doi/epdf/10.1002/1529-0131%28200111%2944%3A11%3C2531%3A%3AAID-ART433%3E3.0.CO%3B2-J
  70. Sripanidkulchai B, Promthep K, Tuntiyasawasdikul S, Tabboon P, Areemit R. Supplementation of Kaempferia parviflora Extract Enhances Physical Fitness and Modulates Parameters of Heart Rate Variability in Adolescent Student-Athletes: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. J Diet Suppl. 2022;19(2):149-167. doi: 10.1080/19390211.2020.1852356; https://www.tandfonline.com/doi/abs/10.1080/19390211.2020.1852356?journalCode=ijds20
  71. Ochiai M, Takeuchi T, Nozaki T, Ishihara KO, Matsuo T. Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor γ Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice. J Food Sci. 2019 Feb;84(2):339-348. doi: 10.1111/1750-3841.14437; https://ift.onlinelibrary.wiley.com/doi/10.1111/1750-3841.14437
  72. Toda, Kazuya et al. “Black ginger extract increases physical fitness performance and muscular endurance by improving inflammation and energy metabolism.” Heliyon vol. 2,5 e00115. 24 May. 2016, doi:10.1016/j.heliyon.2016.e00115 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946221/
  73. Horikawa, Takumi, et al. “Polymethoxyflavonoids from Kaempferia Parviflora Induce Adipogenesis on 3T3-L1 Preadipocytes by Regulating Transcription Factors at an Early Stage of Differentiation.” Biological and Pharmaceutical Bulletin, vol. 35, no. 5, 2012, pp. 686–692; https://www.jstage.jst.go.jp/article/bpb/35/5/35_5_686/_article
  74. Huang J, Tagawa T, Ma S, Suzuki K. Black Ginger (Kaempferia parviflora) Extract Enhances Endurance Capacity by Improving Energy Metabolism and Substrate Utilization in Mice. Nutrients. 2022 Sep 17;14(18):3845. doi: 10.3390/nu14183845; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501856/
  75. Kim, Mi-Bo, et al. “Standardized Kaempferia Parviflora Extract Enhances Exercise Performance through Activation of Mitochondrial Biogenesis.” Journal of Medicinal Food, vol. 21, no. 1, Jan. 2018, pp. 30–38; https://www.liebertpub.com/doi/10.1089/jmf.2017.3989
  76. Chaturapanich G, Chaiyakul S, Verawatnapakul V, Pholpramool C. Effects of Kaempferia parviflora extracts on reproductive parameters and spermatic blood flow in male rats. Reproduction. 2008 Oct;136(4):515-22. doi: 10.1530/REP-08-0069; https://rep.bioscientifica.com/view/journals/rep/136/4/515.xml
  77. Sae-wong C, Tansakul P, Tewtrakul S. Anti-inflammatory mechanism of Kaempferia parviflora in murine macrophage cells (RAW 264.7) and in experimental animals. J Ethnopharmacol. 2009 Jul 30;124(3):576-80. doi: 10.1016/j.jep.2009.04.059; https://www.sciencedirect.com/science/article/abs/pii/S0378874109002876
  78. Sae-Wong C, Matsuda H, Tewtrakul S, Tansakul P, Nakamura S, Nomura Y, Yoshikawa M. Suppressive effects of methoxyflavonoids isolated from Kaempferia parviflora on inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells. J Ethnopharmacol. 2011 Jul 14;136(3):488-95. doi: 10.1016/j.jep.2011.01.013; https://www.sciencedirect.com/science/article/abs/pii/S0378874111000146
  79. Wattanapitayakul SK, Suwatronnakorn M, Chularojmontri L, Herunsalee A, Niumsakul S, Charuchongkolwongse S, Chansuvanich N. Kaempferia parviflora ethanolic extract promoted nitric oxide production in human umbilical vein endothelial cells. J Ethnopharmacol. 2007 Apr 4;110(3):559-62. doi: 10.1016/j.jep.2006.09.037; https://www.sciencedirect.com/science/article/abs/pii/S0378874106005149
  80. Kobayashi, Hiroko et al. “Effect of Kaempferia parviflora extract on knee osteoarthritis.” Journal of natural medicines vol. 72,1 (2018): 136-144. doi:10.1007/s11418-017-1121-6 https://link.springer.com/article/10.1007/s11418-017-1121-6
  81. Ongchai, Siriwan et al. “Kaempferia parviflora Extract Alleviated Rat Arthritis, Exerted Chondroprotective Properties In Vitro, and Reduced Expression of Genes Associated with Inflammatory Arthritis.” Molecules (Basel, Switzerland) vol. 26,6 1527. 11 Mar. 2021, doi:10.3390/molecules26061527; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000004/
  82. “Collagen Type 2 – an Overview | ScienceDirect Topics.” ScienceDirect; https://www.sciencedirect.com/topics/medicine-and-dentistry/collagen-type-2
  83. ‌Lugo JP, Saiyed ZM, Lau FC, Molina JP, Pakdaman MN, Shamie AN, Udani JK. Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr. 2013 Oct 24;10(1):48. doi: 10.1186/1550-2783-10-48; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015808/
  84. Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016 Jan 29;15:14. doi: 10.1186/s12937-016-0130-8; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731911/
  85. Schön C, Knaub K, Alt W, Durkee S, Saiyed Z, Juturu V. UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study. J Integr Complement Med. 2022 Jun;28(6):540-548. doi: 10.1089/jicm.2021.0365; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232232/
  86. Aggarwal, Bharat, et al. “Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses.” Molecules, vol. 20, no. 1, 24 Dec. 2014, pp. 185–205, 10.3390/molecules20010185; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272158/
  87. Begum, A. N., et al. “Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease.” Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, 14 Apr. 2008, pp. 196–208, 10.1124/jpet.108.137455; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527621/
  88. Park, Sunmin et al. “Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats.” Genes & nutrition vol. 11 2. 17 Mar. 2016, doi:10.1186/s12263-016-0520-4; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959551/
  89. Lin, Hang-Ching, et al. “Method for Enhancing Nutrient Absorption with Astragalosides”; United States Patent and Trademark Office; Patent US20120196816A1; August 2, 2012; https://patents.google.com/patent/US20120196816A1/
  90. Lin, Hang-Ching, et al. “Method for Enhancing Nutrient Absorption with Astragalosides”; United States Patent and Trademark Office; Patent US20120196817A1; August 2, 2012; https://patents.google.com/patent/US20120196817A1/
  91. Lin, Hang-Ching, et al. “Method for Enhancing Nutrient Absorption with Astragalosides”; United States Patent and Trademark Office; Patent US8197860B2; June 12, 2012; https://patents.google.com/patent/US8197860B2/en
  92. Lin, Hang-Ching, et al. “Compound for enhancing nutrients uptake”; Taiwan Intellectual Property Office; Patent TWI271195B; 28-Dec 2004; https://patents.google.com/patent/TWI271195B/en
  93. Lee, Shih-Yu, et al. “Astragaloside II Promotes Intestinal Epithelial Repair by Enhancing L-Arginine Uptake and Activating the MTOR Pathway.” Scientific Reports, vol. 7, no. 1, 26 Sept. 2017, p. 12302, 10.1038/s41598-017-12435-y. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614914/
  94. Bhardwaj, R. et al. Aug. 2002. “Piperine, A Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4.” The Journal of Pharmacology and Experimental Therapeutics vol. 302, 2. 645-50; https://pubmed.ncbi.nlm.nih.gov/12130727/
  95. Maeda A, Shirao T, Shirasaya D, Yoshioka Y, Yamashita Y, Akagawa M, Ashida H. Piperine Promotes Glucose Uptake through ROS-Dependent Activation of the CAMKK/AMPK Signaling Pathway in Skeletal Muscle. Mol Nutr Food Res. 2018 Jun;62(11):e1800086. doi: 10.1002/mnfr.201800086; https://pubmed.ncbi.nlm.nih.gov/29683271/
  96. Choi S, Choi Y, Choi Y, Kim S, Jang J, Park T. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Food Chem. 2013 Dec 15;141(4):3627-35. doi: 10.1016/j.foodchem.2013.06.028; https://pubmed.ncbi.nlm.nih.gov/23993530/
  97. Mittal R, Gupta RL. In vitro antioxidant activity of piperine. Methods Find Exp Clin Pharmacol. 2000 Jun;22(5):271-4. doi: 10.1358/mf.2000.22.5.796644; https://pubmed.ncbi.nlm.nih.gov/11031726/
  98. He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015 May 20;20(5):9183-213. doi: 10.3390/molecules20059183; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272784/
  99. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6. doi: 10.1055/s-2006-957450. PMID: 9619120. https://pubmed.ncbi.nlm.nih.gov/9619120/

Comments and Discussion (Powered by the PricePlow Forum)